SCHEMBL19966547

SCHEMBL19966547

CCN1CCN(c2ccc(Nc3ncc(F)c(-c4cc(F)c5[nH]c(C)c(C(C)C)c5c4)n3)nc2)C(=O)C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK6 Q00534 19/20 0.48
CDK4 P11802 14/20 0.48
CDK2 P24941 13/20 0.48
CCND3 P30281 12/20 0.48
CCNA2 P20248 12/20 0.48
CDK1 P06493 11/20 0.48
CCNE2 O96020 8/20 0.48
CCND1 P24385 7/20 0.47
CDK5 Q00535 3/20 0.46
CCNT1 O60563 3/20 0.46
CDK9 P50750 3/20 0.46
CCNB1 P14635 3/20 0.46
CCNE1 P24864 3/20 0.46
CDK7 P50613 2/20 0.46
CCNH P51946 2/20 0.46
MNAT1 P51948 2/20 0.46
KCNH2 Q12809 2/20 0.46
CDK5R1 Q15078 2/20 0.46
CIT O14578 1/20 0.46
GAK O14976 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19966656 0.89 CDK6 (0.60) CDK6CDK4CDK2CCND3CCNA2
SCHEMBL19966658 0.86 CDK6 (0.64) CDK6CDK4CDK2CCND3CCNA2
SCHEMBL19966332 0.85 CDK6 (0.57) CDK6CDK4CDK2CCND3CCNA2
SCHEMBL19966451 0.84 CDK6 (0.64) CDK6CDK4CDK2CCND3CCNA2
SCHEMBL19966325 0.83 CDK6 (0.61) CDK6CDK4CCND3CCND1PIM1
SCHEMBL19966655 0.82 CDK6 (0.64) CDK6CDK4CDK2CCND3CCNA2
SCHEMBL19966570 0.82 CDK4 (0.65) CDK6CDK4CDK2CCND3CCNA2
SCHEMBL19966567 0.81 CDK6 (0.49) CDK6CDK4CDK2CCND3CCNA2
SCHEMBL19966604 0.80 CDK4 (0.49) CDK6CDK4CDK2CCND3CCNA2
SCHEMBL19966659 0.79 CDK4 (0.62) CDK6CDK4CDK2CCND3CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018045957-A1 CDK4/6 INHIBITOR AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 江苏豪森药业集团有限公司 2018-03-15 WO disclosed